Navigation Links
PLC Systems Reports First Quarter 2009 Results

FRANKLIN, Mass., May 7 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three month period ended March 31, 2009.

First quarter 2009 total revenues were $1,567,000, up from $1,168,000 in the first quarter of 2008. The net loss for the first quarter of 2009 was $358,000, or $0.01 per diluted share, compared to a net loss of $762,000, or $0.03 per diluted share, in the first quarter of 2008.

Mark R. Tauscher, president and chief executive officer of PLC Systems Inc., stated, "Our first quarter financial results reflect the positive impact we experienced from increased international revenues this past quarter stemming from our first CO2 Heart Laser (HL2) sale in Bangladesh. In addition we benefited in the first quarter this year from our ongoing cost containment efforts which resulted in lower overall operating expenses, most notably a reduction in U.S. clinical trial-related expenditures for our RenalGuard(R) technology due to the delay in commencing the next phase of the trial."

PLC announced on May 4, 2009, that it had entered into a five-year exclusive agreement with IZASA Distribuciones Tecnicas S.A., headquartered in Barcelona, Spain, for the distribution of its RenalGuard System(TM) in Spain. IZASA is one of Spain's leading distributors of interventional cardiology-related medical devices, and a part of the Werfen Group, a privately owned international healthcare corporation. IZASA joins Artech Spa, the Company's exclusive distributor for RenalGuard products in Italy, in PLC's European launch of RenalGuard.

During the first quarter of 2009, PLC recorded one new HL2 sale internationally; there were no domestic laser sales. In the same quarter of 2008, PLC recorded one new HL2 sale to a U.S. hospital through Novadaq Technologies, PLC's U.S. marketing and distribution partner for its TMR products. PLC ended the first quarter of 2009 with 169 HL2 CO2 Heart Lasers located at heart centers throughout the U.S.

During the first quarter of 2009, 347 disposable TMR kits were shipped, consisting of 332 kits shipped to hospitals in the U.S. by Novadaq and 15 kits shipped internationally by PLC. In comparison, a total of 390 disposable TMR kits were shipped worldwide during the first quarter of 2008.

Conference Call

PLC Systems will host a conference call today, May 7, 2009, at 11:00 a.m. ET to discuss these matters. The call may be joined by dialing (866) 825-1709, or internationally, (617) 213-8060, at least ten minutes prior to the start of the call. The passcode is 67477077. A live webcast of the call will be accessible at the investor relations section of the Company's website at An archived webcast of the conference call will be available beginning one hour after the completion of the call in the same location.

About PLC Systems Inc.

PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, Massachusetts, PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, RenalGuard, is approved for sale in the EU as a general fluid balancing device. Additional company information can be found at

This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward-looking statements. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and you should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of important factors, including that we may not receive necessary regulatory approvals to market our RenalGuard product or that such approvals may be withdrawn, we may be unable to raise sufficient funds in the future to implement our business plan and/or commence our planned U.S. clinical trial for RenalGuard, the current clinical trial in Italy and the planned future U.S. clinical trial for RenalGuard as a safe and effective prevention device for contrast induced nephropathy may not be completed in a timely fashion, if at all, or, if these clinical trials are completed, they may not produce clinically significant or meaningful results, the RenalGuard product may not be commercially accepted, operational changes, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, and additional risk factors described in the "Forward Looking Statements" section of our Annual Report on Form 10-K for the year ended December 31, 2008, and our other SEC reports.

PLC Systems, PLC Medical Systems, PLC, CO2 Heart Laser, RenalGuard and RenalGuard System are trademarks of PLC Systems Inc.

Novadaq is a trademark of Novadaq Technologies, Inc.

    Contact:  Mary T. Conway
              Conway Communications

                            PLC SYSTEMS INC.
                   (In thousands, except per share data)

                                                             Three Months
                                                               March 31,
                                                           2009         2008

      Product sales                                      $1,259         $806
      Service fees                                          308          362
        Total revenues                                    1,567        1,168

    Cost of revenues:
      Product sales                                         411          220
      Service fees                                          201          185
        Total cost of revenues                              612          405
    Gross profit                                            955          763

    Operating expenses:
      Selling, general and administrative                 1,085          970
      Research and development                              229          608
        Total operating expenses                          1,314        1,578

    Loss from operations                                   (359)        (815)
    Other income, net                                         1           53
    Net loss                                              $(358)       $(762)
    Basic and diluted loss per share                     $(0.01)      $(0.03)

    Average shares outstanding:
       Basic and diluted                                 30,351       30,329

                              CONDENSED BALANCE SHEET

                                                       March 31, December 31,
                                                           2009         2008
    Cash and cash equivalents                            $4,319       $5,026
    Total current assets                                  6,414        7,562
    Total assets                                          6,738        7,913
    Total current liabilities                             2,777        3,364
    Shareholders' equity                                  2,876        3,191

SOURCE PLC Systems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
2. Frost & Sullivan: Shift from Analog Mammography Systems to Digital Mammography Systems Will Boost the European Mammography Systems Market
3. IH Systems Extends Global Reach into South Korean Medical Device Market
4. Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe
5. Ingenuity Systems Announces Multi-Year Deal With AstraZeneca
6. Neogen Acquires International Diagnostic Systems
7. Healthcare Management Systems Celebrates 25 Years
8. Electronic prescribing systems boost efficiency, may lead to improved quality of care
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Dynasplint Systems, Inc. Launches Two New Web Sites Plus Social Media Tools
11. IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health ... launches new Wimbledon Athletics Facebook page to educate the public, parents ... cardiac abnormalities. About 2,000 people under the age of 25 die from sudden ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a ... tracking systems. The new app features a more intuitive SleepScore™ that rates sleep quality ... you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 On Tuesday, November ... bellwether trial against Wright Medical Technology, Inc. for ... Conserve metal-on-metal hip implant device, awarded $11 million ... two week trial and three days of deliberations, ... device was defectively designed and unreasonably dangerous, and ...
(Date:11/25/2015)... Allergan plc (NYSE: AGN ) today announced that it ... State Attorney General,s Office to end the litigation ... with the Attorney General over the decision of Forest Laboratories, ... the now generic version of memantine immediate release tablets.  Under ... its counterclaims against New York , and ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Endo International ... Rajiv De Silva , President and CEO, will discuss ... Healthcare Conference in New York on ... . Click on Investor Relations, and then the ... prior to the presentation,s start time to visit the site ...
Breaking Medicine Technology: